Title:
LYSOPHOSPHATIDYLSERINE ANALOGUE, AND LYSOPHOSPHATIDYLSERINE ANALOGUE-CONTAINING PHAMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING FIBROSIS
Document Type and Number:
WIPO Patent Application WO/2023/145873
Kind Code:
A1
Abstract:
The present invention pertains to a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. (The definitions of R1, R2, L, m and n in formula (I) are stated in the specification.)
Inventors:
OHWADA TOMOHIKO (JP)
OTANI YUKO (JP)
CHEN LUYING (JP)
MIYAJIMA ATSUSHI (JP)
KIDO TAKETOMO (JP)
OTANI YUKO (JP)
CHEN LUYING (JP)
MIYAJIMA ATSUSHI (JP)
KIDO TAKETOMO (JP)
Application Number:
PCT/JP2023/002625
Publication Date:
August 03, 2023
Filing Date:
January 27, 2023
Export Citation:
Assignee:
UNIV TOKYO (JP)
International Classes:
A61P1/00; A61K31/685; A61P1/18; A61P7/00; A61P9/00; A61P11/00; A61P13/12; A61P17/00; A61P25/28; A61P27/02; C07F9/09
Domestic Patent References:
| WO2012157746A1 | 2012-11-22 | |||
| WO2014119649A1 | 2014-08-07 | |||
| WO2015152412A1 | 2015-10-08 |
Foreign References:
| JP2016179959A | 2016-10-13 | |||
| JP2020537657A | 2020-12-24 |
Attorney, Agent or Firm:
INABA, Yoshiyuki et al. (JP)
Download PDF:
Previous Patent: METHOD AND COMPOSITION FOR STABILISING NICOTINAMIDE ADENINE DINUCLEOTIDE
Next Patent: NOVEL MONOCLONAL ANTIBODY AGAINST CORONA VIRUS
Next Patent: NOVEL MONOCLONAL ANTIBODY AGAINST CORONA VIRUS